Targets for astrocyte-based treatments of Parkinson's disease (PD).
作者信息
Parmar Malin
机构信息
Developmental and Regenerative Neurobiology, Wallenberg Neuroscience Center, Lund Stem Cell Center, Department of Experimental Medical Science, Lund University, 22184 Lund, Sweden.
出版信息
Proc Natl Acad Sci U S A. 2022 Jul 26;119(30):e2208876119. doi: 10.1073/pnas.2208876119. Epub 2022 Jul 18.
Abstract
摘要
相似文献
1
Targets for astrocyte-based treatments of Parkinson's disease (PD).基于星形胶质细胞的帕金森病（PD）治疗靶点。
Proc Natl Acad Sci U S A. 2022 Jul 26;119(30):e2208876119. doi: 10.1073/pnas.2208876119. Epub 2022 Jul 18.
2
Astrocytes Protect Human Dopaminergic Neurons from α-Synuclein Accumulation and Propagation.星形胶质细胞可防止人多巴胺能神经元中α-突触核蛋白的积累和传播。
J Neurosci. 2020 Nov 4;40(45):8618-8628. doi: 10.1523/JNEUROSCI.0954-20.2020. Epub 2020 Oct 12.
3
Therapeutic functions of astrocytes to treat α-synuclein pathology in Parkinson's disease.星形胶质细胞在治疗帕金森病 α-突触核蛋白病中的治疗作用。
Proc Natl Acad Sci U S A. 2022 Jul 19;119(29):e2110746119. doi: 10.1073/pnas.2110746119. Epub 2022 Jul 15.
4
The deglycase activity of DJ-1 mitigates α-synuclein glycation and aggregation in dopaminergic cells: Role of oxidative stress mediated downregulation of DJ-1 in Parkinson's disease.DJ-1 的去糖基化酶活性减轻多巴胺能细胞中α-突触核蛋白的糖基化和聚集：氧化应激介导的 DJ-1 下调在帕金森病中的作用。
Free Radic Biol Med. 2019 May 1;135:28-37. doi: 10.1016/j.freeradbiomed.2019.02.014. Epub 2019 Feb 20.
5
Crosstalk between astrocytes and microglia results in increased degradation of α-synuclein and amyloid-β aggregates.星形胶质细胞和小胶质细胞之间的串扰导致 α-突触核蛋白和淀粉样-β 聚集物的降解增加。
J Neuroinflammation. 2021 Jun 3;18(1):124. doi: 10.1186/s12974-021-02158-3.
6
Astrocytic expression of Parkinson's disease-related A53T alpha-synuclein causes neurodegeneration in mice.帕金森病相关 A53T ɑ-突触核蛋白在星形胶质细胞中的表达导致小鼠神经退行性变。
Mol Brain. 2010 Apr 21;3:12. doi: 10.1186/1756-6606-3-12.
7
Patient-Specific iPSC-Derived Astrocytes Contribute to Non-Cell-Autonomous Neurodegeneration in Parkinson's Disease.患者特异性 iPSC 衍生星形胶质细胞在帕金森病中非细胞自主神经退行性变中发挥作用。
Stem Cell Reports. 2019 Feb 12;12(2):213-229. doi: 10.1016/j.stemcr.2018.12.011. Epub 2019 Jan 10.
8
Depopulation of dense α-synuclein aggregates is associated with rescue of dopamine neuron dysfunction and death in a new Parkinson's disease model.α-突触核蛋白致密聚集体的耗散与一种新的帕金森病模型中多巴胺能神经元功能障碍和死亡的挽救有关。
Acta Neuropathol. 2019 Oct;138(4):575-595. doi: 10.1007/s00401-019-02023-x. Epub 2019 May 31.
9
FK506 reduces neuroinflammation and dopaminergic neurodegeneration in an α-synuclein-based rat model for Parkinson's disease.在基于α-突触核蛋白的帕金森病大鼠模型中，FK506可减轻神经炎症和多巴胺能神经变性。
Neurobiol Aging. 2015 Mar;36(3):1559-68. doi: 10.1016/j.neurobiolaging.2015.01.014. Epub 2015 Jan 21.
10
Parkinson's Disease-Associated LRRK2 Interferes with Astrocyte-Mediated Alpha-Synuclein Clearance.帕金森病相关 LRRK2 干扰星形胶质细胞介导的α-突触核蛋白清除。
Mol Neurobiol. 2021 Jul;58(7):3119-3140. doi: 10.1007/s12035-021-02327-8. Epub 2021 Feb 24.
引用本文的文献
1
Perivascular macrophages in the central nervous system: insights into their roles in health and disease.中枢神经系统中的血管周围巨噬细胞：对其在健康与疾病中作用的见解
Cell Death Dis. 2025 Apr 28;16(1):350. doi: 10.1038/s41419-025-07592-2.
2
Heteromerization of Dopamine D2 and Oxytocin Receptor in Adult Striatal Astrocytes.成年纹状体星形胶质细胞中多巴胺 D2 和催产素受体的异源二聚化。
Int J Mol Sci. 2023 Feb 28;24(5):4677. doi: 10.3390/ijms24054677.
本文引用的文献
1
Therapeutic functions of astrocytes to treat α-synuclein pathology in Parkinson's disease.星形胶质细胞在治疗帕金森病 α-突触核蛋白病中的治疗作用。
Proc Natl Acad Sci U S A. 2022 Jul 19;119(29):e2110746119. doi: 10.1073/pnas.2110746119. Epub 2022 Jul 15.
2
Neurons and Glia Interplay in α-Synucleinopathies.神经元和神经胶质细胞在α-突触核蛋白病中的相互作用。
Int J Mol Sci. 2021 May 8;22(9):4994. doi: 10.3390/ijms22094994.
3
Single cell transcriptomics identifies stem cell-derived graft composition in a model of Parkinson's disease.单细胞转录组学鉴定帕金森病模型中干细胞衍生移植物的组成。
Nat Commun. 2020 May 15;11(1):2434. doi: 10.1038/s41467-020-16225-5.
4
Animal models for preclinical Parkinson's research: An update and critical appraisal.用于临床前帕金森研究的动物模型：更新与批判性评价。
Prog Brain Res. 2020;252:27-59. doi: 10.1016/bs.pbr.2020.02.003. Epub 2020 Mar 21.
5
The future of stem cell therapies for Parkinson disease.帕金森病干细胞治疗的未来。
Nat Rev Neurosci. 2020 Feb;21(2):103-115. doi: 10.1038/s41583-019-0257-7. Epub 2020 Jan 6.
6
The Emerging Nature of Astrocyte Diversity.星形胶质细胞多样性的新兴本质。
Annu Rev Neurosci. 2019 Jul 8;42:187-207. doi: 10.1146/annurev-neuro-070918-050443.
7
Toll-like receptors and their therapeutic potential in Parkinson's disease and α-synucleinopathies.Toll 样受体及其在帕金森病和α-突触核蛋白病中的治疗潜力。
Brain Behav Immun. 2019 Oct;81:41-51. doi: 10.1016/j.bbi.2019.06.042. Epub 2019 Jul 2.
8
The A1 astrocyte paradigm: New avenues for pharmacological intervention in neurodegeneration.A1 星形胶质细胞范式：神经退行性变中药物干预的新途径。
Mov Disord. 2019 Jul;34(7):959-969. doi: 10.1002/mds.27718. Epub 2019 May 28.
9
The Emerging Evidence of the Parkinson Pandemic.帕金森病大流行的新证据。
J Parkinsons Dis. 2018;8(s1):S3-S8. doi: 10.3233/JPD-181474.
10
Lewy body-like alpha-synuclein inclusions trigger reactive microgliosis prior to nigral degeneration.路易小体样α-突触核蛋白包涵体在黑质变性前引发反应性小胶质细胞增生。
J Neuroinflammation. 2018 May 1;15(1):129. doi: 10.1186/s12974-018-1171-z.
Zotero 插件